Vitamins on Tirzepatide: Biomarker-Guided Supplementation

Last reviewed: May 31, 2026

Last updated: May 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Tirzepatide therapy—whether compounded or branded—can alter nutrient absorption and metabolism, potentially creating gaps in B vitamins, fat-soluble vitamins, and minerals. A 2023 analysis in Obesity Surgery found GLP-1 and GIP receptor agonists may reduce intrinsic factor and gastric acid, affecting B12, folate, and mineral bioavailability. Strategic supplementation with provider oversight helps maintain nutritional status during treatment.

Personalized supplementation depends on baseline micronutrient status, genetic factors affecting nutrient metabolism, and individual absorption capacity. PlexusDx emphasizes precision-wellness by contextualizing supplementation within each patient's biomarker profile and genetic predispositions—ensuring supplements address real deficiency risk rather than generic recommendations.

How Tirzepatide Affects Nutrient Absorption and Metabolism

Tirzepatide slows gastric emptying and reduces appetite signals, which may decrease overall nutrient intake and alter stomach acid production needed for mineral and B12 absorption. Rapid weight loss also mobilizes fat-soluble vitamins (A, D, E, K) stored in fat tissue, potentially creating temporary imbalances. Research in Diabetes Care (2022) noted GIP/GLP-1 agonists correlate with reduced intrinsic factor secretion, increasing B12 malabsorption risk.

Individual variation in these effects depends on baseline metabolic health, age, and genetic factors affecting nutrient transport pathways. Some patients maintain adequate levels with diet alone; others require supplementation within weeks of starting therapy. Baseline biomarker testing—including B12, folate, vitamin D, iron, and magnesium—provides objective data to guide supplementation.

Essential Vitamins and Minerals During Tirzepatide Therapy: Evidence-Based Recommendations

Clinical evidence supports targeted supplementation for several micronutrients during GLP-1/GIP therapy. The table below summarizes key vitamins, their roles, typical deficiency signs, and evidence-based supplementation approaches. All recommendations should be individualized based on baseline biomarkers and provider assessment.

Nutrient	Why It Matters on Tirzepatide	Typical Dose Range	Deficiency Signs to Monitor
Vitamin B12	Reduced intrinsic factor lowers absorption; risk increases with therapy duration	1,000–2,000 mcg monthly or 500–1,000 mcg daily sublingual	Fatigue, neuropathy, cognitive changes, macrocytic anemia
Folate (B9)	Decreased gastric acid and reduced intake lower bioavailability	400–800 mcg daily (methylfolate form preferred for some genetic variants)	Anemia, mouth sores, elevated homocysteine
Vitamin D	Mobilization from fat stores during rapid weight loss; reduced sun exposure from dietary changes	1,000–4,000 IU daily; target 30–50 ng/mL 25-OH-D	Bone loss, mood changes, immune dysfunction
Iron	Reduced gastric acid and meat intake lower heme-iron absorption	18–27 mg elemental iron daily (with vitamin C for absorption); tailor to sex and baseline	Fatigue, shortness of breath, hair loss, cold sensitivity
Magnesium	Reduced intake and increased urinary losses during weight loss	300–400 mg daily; glycinate or threonate forms better tolerated	Muscle cramps, arrhythmias, constipation worsening
Calcium	Low stomach acid impairs absorption; weight loss increases bone turnover	1,000–1,200 mg daily (citrate form for lower pH absorption)	Bone pain, dental issues, muscle weakness
Zinc	Reduced intake and absorption; important for immune and metabolic health	8–15 mg daily (with food to reduce GI upset)	Hair loss, slow wound healing, taste changes

Biomarker Testing as a Guide to Personalized Supplementation Strategy

Rather than supplement based on generic recommendations, biomarker testing provides objective baselines for nutrient status before and during tirzepatide therapy. Recommended pre-treatment labs include serum B12, folate, vitamin D (25-OH), iron panel, magnesium, and homocysteine. Testing again at 3 and 12 months of therapy identifies emerging gaps and guides dose adjustments.

Patients with specific genetic variants affecting nutrient absorption—such as polymorphisms in folate metabolism (MTHFR) or B12 transport (FI)—may benefit from targeted supplementation form selection. For example, methylfolate supplementation may be more effective for patients carrying certain MTHFR variants. PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic and nutrient-handling pathways, allowing providers to frame supplementation more strategically within each patient's genetic context.

Safety Considerations and Provider-Guided Supplementation Protocols

Supplementation during tirzepatide therapy requires careful coordination with overall medical management. Certain supplements interact with medications (iron with thyroid drugs; magnesium with antibiotics); some patients have genetic sensitivities or absorption disorders requiring specialist input. Always disclose all supplements to your healthcare provider before and during treatment. Exceeding recommended doses of fat-soluble vitamins (A, D, E, K) carries toxicity risk, particularly during rapid weight loss when mobilization is already elevated.

A structured supplementation protocol—informed by baseline biomarkers, genetic predispositions, and clinical presentation—reduces guesswork and optimizes outcomes. Work with your provider to establish a baseline lab panel, select forms and doses matched to your absorption capacity and genetic profile, and reschedule labs at 3 and 12 months to assess effectiveness. This systematic approach transforms supplementation from generic prevention into precision support aligned with your individual treatment response.

How PlexusDx Supports a More Personalized Approach

PlexusDx's approach to tirzepatide supplementation guidance integrates biomarker awareness with genetic context. Understanding how individual variants in nutrient-absorption pathways influence micronutrient handling may help provide context for supplement selection and dosing—but genetic predisposition alone does not predict exact supplementation needs. Biomarker testing remains the gold standard for quantifying real deficiency risk.

The Precision Peptide Genetic Test reveals predispositions in several metabolic pathways relevant to nutrient handling, including folate metabolism (MTHFR variants), iron transport, and magnesium metabolism. These insights should be interpreted with a qualified healthcare provider as part of a broader assessment that includes baseline lab work and clinical evaluation. The test does not predict exact supplementation response or guarantee nutrient optimization.

By combining compounded tirzepatide prescription with biomarker-guided supplementation and genetic context, patients and providers gain a more complete picture of individual nutritional needs during treatment. This precision-wellness framework transforms supplementation from guesswork into informed, personalized support—helping ensure tirzepatide therapy achieves its therapeutic goals without compromising micronutrient status.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $229-$509/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.